Singlet oxygen scavenging activity of non-steroidal anti-inflammatory drugs

Redox Report

Volumn 13, Issue 4, 2008, Pages 153-160

  Costa, David ^a   Gomes, Ana ^a   Lima, José L F C ^a   Fernandes, Eduarda ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

3 (1,4 naphthalene)bispropionate (NDPO2); Dihydrorhodamine 123; Endoperoxide of disodium 3; Microplate screening assay; NSAIDs; Singlet oxygen

Indexed keywords

AMINOPHENAZONE; DIHYDRORHODAMINE 123; DIPYRONE; DISODIUM 3,3' ( 1,4 NAPHTHALENE)BISPROPIONATE; ETODOLAC; INDOMETACIN; INDOPROFEN; KETOROLAC; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OXAPROZIN; OXYGEN DERIVATIVE; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; SULINDAC SULFIDE; SULINDAC SULFONE; TOLMETIN; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CHRONIC INFLAMMATION; DRUG POTENCY; DRUG STRUCTURE; ENZYME INHIBITION; OXIDATION; PRIORITY JOURNAL;

AMINOPYRINE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIPYRONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ETODOLAC; FREE RADICAL SCAVENGERS; INDOPROFEN; KETOROLAC; MOLECULAR STRUCTURE; NAPROXEN; PROPIONIC ACIDS; SINGLET OXYGEN; TOLMETIN;

EID: 57349098211     PISSN: 13510002     EISSN: None     Source Type: Journal    
DOI: 10.1179/135100008X308876     Document Type: Article

References (39)

1. Kapoor M, Clarkson AN, Sutherland BA, Appleton I. The role of antioxidants in models of inflammation: Emphasis on L-arginine and arachidonic acid metabolism. Inflammopharmacology 2005; 12: 505-519.
2. Ferrè N, Clária J. New insights into the regulation of liver inflammation and oxidative stress. Mini Rev Med Chem 2006; 6: 1321-1330.
3. Halliwell B. Phagocyte-derived reactive species: Salvation or suicide? Trends Biochem Sci 2006; 31: 509-515.
4. Geronikaki AA, Gavalas AM. Antioxidants and inflammatory disease: synthetic and natural antioxidants with anti-inflammatory activity. Comb Chem High Throughput Screen 2006; 9: 425-442.
5. Aruoma OI, Halliwell B. The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugs. Xenobiotica 1988; 18: 459-470.
6. Parij N, Nagy AM, Neve J. Linear and non linear competition plots in the deoxyribose assay for determination of rate constants for reaction of nonsteroidal antiinflammatory drugs with hydroxyl radicals. Free Radic Res 1995; 23: 571-579.
7. Fernandes E, Toste SA, Lima JL, Reis S. The metabolism of sulindac enhances its scavenging activity against reactive oxygen and nitrogen species. Free Radic Biol Med 2003; 35: 1008-1017.
8. Fernandes E, Costa D, Toste SA, Lima JL, Reis S. In vitro scavenging activity for reactive oxygen and nitrogen species by nonsteroidal anti-inflammatory indole, pyrrole, and oxazole derivative drugs. Free Radic Biol Med 2004; 37: 1890-1895.
9. Costa D, Gomes A, Reis S, Lima JL, Fernandes E. Hydrogen peroxide scavenging activity by non-steroidal anti-inflammatory drugs. Life Sci 2005; 76: 2841-2848.
10. Costa D, Moutinho L, Lima JL, Fernandes E. Antioxidant activity and inhibition of human neutrophil oxidative burst mediated by arylpropionic acid non steroidal anti-inflammatory drugs. Biol Pharm Bull 2006; 29: 1659-1670.
11. Costa D, Vieira A, Fernandes E. Dipyrone and aminopyrine are effective scavengers of reactive nitrogen species. Redox Rep 2006; 11: 136-142.
12. Costa D, Marques AP, Reis RL, Lima JL, Fernandes E. Inhibition of human neutrophil oxidative burst by pyrazolone derivatives. Free Radic Biol Med 2006; 40: 632-640.
13. Wentworth Jr P, McDunn JE, Wentworth AD et al. Evidence for antibody-catalyzed ozone formation in bacterial killing and inflammation. Science 2002; 298: 2195-2199.
14. Wentworth Jr P, Nieva J, Takeuchi C et al. Evidence for ozone formation in human atherosclerotic arteries. Science 2003; 302: 1053-1056.
15. Fubini B, Hubbard A. Reactive oxygen species (ROS) and reactive nitrogen species (RNS) generation by silica in inflammation and fibrosis. Free Radic Biol Med 2003; 34: 1507-1516.
16. Schiller J, Fuchs B, Arnhold J, Arnold K. Contribution of reactive oxygen species to cartilage degradation in rheumatic diseases: Molecular pathways, diagnosis and potential therapeutic strategies. Curr Med Chem 2003; 10: 2123-2145.
17. Symons AM, King LJ. Inflammation, reactive oxygen species and cytochrome P450. Inflammopharmacology 2003; 11: 75-86.
18. Miyamoto S, Ronsein GE, Prado FM et al. Biological hydroperoxide and singlet molecular oxygen generation. IUBMB Life 2007; 59: 323-331.
19. Gomes A, Fernandes E, Lima JLFC. Use of fluorescence probes for detection of reactive nitrogen species: A review. J Fluoresc 2006, 16: 119-139.
20. Russell GA. Deuterium-isotope effects in the autoxidation of aralkyl hydrocarbons-mechanism of the interaction of peroxy radicals. J Am Chem Soc 1957; 79: 3871-3877.
21. Dedon PC, Tannenbaum SR. Reactive nitrogen species in the chemical biology of inflammation. Arch Biochem Biophys 2004; 423: 12-22.
22. Costa D, Fernandes E, Santos JL, Pinto DC, Silva AM, Lima JL. New noncellular fluorescence microplate screening assay for scavenging activity against singlet oxygen. Anal Bioanal Chem 2007; 387: 2071-2081.
23. Steinbeck MJ, Khan AU, Karnovsky MJ. Intracellular singlet oxygen generation by phagocytosing neutrophils in response to particles coated with a chemical trap. J Biol Chem 1992; 267: 13425-13433
24. Steinbeck MJ, Khan AU, Karnovsky MJ. Extracellular production of singlet oxygen by stimulated macrophages quantified using 9,10-diphenylanthracene and perylene in a polystyrene film. J Biol Chem 1993; 268: 15649-15654.
25. Mayeda EA, Bard AJ. Singlet oxygen. The suppression of its production in dismutation of superoxide ion by superoxide dismutase. J Am Chem Soc 1974; 96: 4023-4024.
26. Epe B. Genotoxicity of singlet oxygen. Chem Biol Interact 1991; 80: 239-260.
27. Bentur Y, Cohen O. Dipyrone overdose. J Toxicol Clin Toxicol 2004; 42: 261-265.
28. Volz M, Kellner HM. Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone). Br J Clin Pharmacol 1980; 10: 299S-308S.
29. Sayo H, Saito M. The mechanism of myeloperoxidase-catalysed oxidation of aminopyrine. Xenobiotica 1990; 9: 957-965.
30. Kalyanaraman B, Sohnle PG. Generation of free radical intermediates from foreign compounds by neutrophil-derived oxidants. J Clin Invest 1985; 75: 1618-1622.
31. Jones RW, Collins AJ, Notarianni LJ, Sedman E. The comparative pharmacokinetics of acemetacin in young subjects and elderly patients. Br J Clin Pharmacol 1991; 31: 543-545.
32. Duggan DE, Hare LE, Ditzler CA, Lei BW, Kwan KC. The disposition of sulindac. Clin Pharmacol Ther 1977; 21: 326-335.
33. Duggan DE, Hooke KF, Hwang SS. Kinetics of the tissue distributions of sulindac and metabolites. Relevance to sites and rates of bioactivation. Drug Metab Dispos 1980; 8: 241-246.
34. Duggan DE, Hooke KF, Risley EA, Shen TY, Arman CG. Identification of the biologically active form of sulindac. J Pharmacol Exp Ther 1977; 201: 8-13.
35. Netter P, Bannwarth B, Royer-Morrot MJ. Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid. Clin Pharmacokinet 1989; 17: 145-162.
36. Urquhart E. A comparison of synovial fluid concentrations of non-steroidal antiinflammatory drugs with their in vitro activity. Agents Actions 1991; 32: 261-265.
37. Graf P, Glatt M, Brune K. Acidic nonsteroid anti-inflammatory drugs accumulating in inflamed tissue. Experientia 1975; 31: 951-953.
38. Sousa T, Fernandes E, Nunes C et al. Scavenging of nitric oxide by an antagonist of adenosine receptors. J Pharm Pharmacol 2005; 57: 399-404.
39. Stetinova V, Smetanova L, Grossmann V, Anzenbacher P. In vitro and in vivo assessment of the antioxidant activity of melatonin and related indole derivatives. Gen Physiol Biophys 2002; 21: 153-162.